Print
Email
Print Edition StoriesFriday, June 20, 2008
Sciformix gets $3.3M in first round funding
By Mass High Tech Staff
Sciformix Corp., a provider of knowledge process outsourcing for the life sciences industry, has raised $3.3 million in a Series A round of financing from a local venture capital firm, according to the company.
Flybridge Capital Partners of Boston was the sole investor in Westborough-based Sciformix’s first round of venture capital. As a result of the financing, Flybridge general partner Chip Hazard has secured a seat on the board of directors at Sciformix.
Sciformix, which has operations in the United States and India, said it enables life sciences concerns to outsource drug-safety management work such as biostatistics, clinical data management and regulatory document writing. The drug-safety and clinical data management markets are estimated to be $820 million per year and growing, company CEO Dinesh Thakur said in a statement.
Flybridge, formerly IDG Ventures Atlantic, said it is focused on investments in early-stage companies in the consumer, health care and information technology industries. The firm has $560 million under management.
Comments
If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.
RSS Feeds
